NABI AWARDED $7 MILLION NAVY TESTING CONTRACT
NABI AWARDED $7 MILLION NAVY TESTING CONTRACT MIAMI, Aug. 17 /PRNewswire/ -- North American Biologicals, Inc.
("NABI") (NASDAQ: NBIO) today announced it has received a three-year HIV testing contract, valued at approximately $7 million, from the United States Navy. NABI has been conducting HIV testing for the Navy since 1989 under a similar contract, which expires this month.
"NABI has emerged in recent years as one of the leaders in the field of AIDS testing, which is still the most effective measure for early diagnosis and treatment," said David J. Gury, NABI's chairman, president and CEO. "As a part of our testing business, we will continue to develop quality control products and testing services that contribute to the overall national effort to eradicate this disease." The Naval contract involves testing for new personnel, periodic testing of existing personnel, and testing for personnel relocating overseas. Tests are conducted at NABI's testing laboratory in Miami and results are reported to the Bethesda Naval Hospital. North American Biologicals, Inc. is the world's largest independent provider of human blood plasma elements to the health care industry. The company collects, processes, tests and distributes human blood- related products, manufactures and markets plasma/sera-based diagnostic products and markets clinical diagnostic testing services. -0- 8/17/92 /CONTACT: David J. Gury, president, or Alfred J. Fernandez, VP finance, North American Biologicals, 305-628-0880; or Lori E. Martin, Feinstein Partners, 617-577-8110, for North American Biologicals, Inc./ (NBIO) CO: North American Biologicals, Inc. ST: IN: MTC SU: CON
CH -- NE006 -- 0499 08/17/92 12:09 EDT
|Printer friendly Cite/link Email Feedback|
|Date:||Aug 17, 1992|
|Previous Article:||THE JOURNAL OF CLINICAL MICROBIOLOGY REPORTS THAT A NEW FDA-APPROVED AIDS TEST WILL IMPROVE SPECIFICITY OF HIV CONFIRMATORY TESTING|
|Next Article:||FANNIE MAE DEBENTURE REDEMPTION|